3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
1
Meningioma
1
Medulloblastoma
1
Interventions
Magnetic Resonance Spectroscopy
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
gallium Ga 68 dotatate
1
arginyllysine
1
Whole Body Imaging
1
TIC10 compound
1
Hematologic Tests
1
Gadolinium DTPA
1
Biopsy
1
Amino Acids
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Meningioma
×
90Y-octreotide, DOTA-Tyr(3)-
×
Clear all
NCT03013387
2017-08-25
Dosimetry Guided PRRT With 90Y-DOTATOC
University of Iowa
Phase 2
Withdrawn